Response to the Letter to the Editor Entitled “Critical Reappraisal of Obinutuzumab Randomized Trials in Membranous Nephropathy”

By afschroeder • August 2, 2026

Giri K, Glassock RJ, Fervenza FC. Response to the Letter to the Editor Entitled "Critical Reappraisal of Obinutuzumab Randomized Trials in Membranous Nephropathy". Kidney Int Rep. 2026 Jun 6;11(9):106658. doi: 10.1016/j.ekir.2026.106658. PMID: 42541134; PMCID: PMC13427534.

Tags: Emeritus, Harbor UCLA, Nephrology, Publications

Multifactorial causes of severe persistent hypercalcemia in an immunosuppressed woman with chronic kidney disease

Nalluri K, Goodman EL, Pasupneti T, Nunez G, Wang EC. Multifactorial causes of severe persistent hypercalcemia in an immunosuppressed woman with chronic kidney disease. JCEM[...]

Effects of normobaric hypoxia and hyperthermia on ventilatory responses to high-intensity interval training bouts

Girardi M, Nicolò A, Marcora SM, Bazzucchi I, Felici F, Dickinson J, Sacchetti M. Effects of normobaric hypoxia and hyperthermia on ventilatory responses to high-intensity[...]

Agatston-2.0: A next-generation AI-based coronary calcium quantification approach to improve risk stratification among individuals with zero Agatston scores – Part I: An AI-CVD Study within the Multi-Ethnic Study of Atherosclerosis and Framingham Heart Study

Naghavi M, Azimi A, Atlas K, Reeves AP, Zhang C, Mirjalili SR, Mozafarybazargany M, Jolfayi AG, Hashemi A, Atlas T, Wasserthal J, Vliegenthart R, Henschke[...]